Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002441.SZ
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -4.78 2.77 2.91
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 84.90 -3.33 -22.04
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -2.46 8.62 8.84
Cash -4.41 2.56 2.68
Capex -58.47 -0.01 < 0.005
Free Cash Flow -92.55 0.07 0.95
Revenue -26.72 4.21 5.75
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 63.82 0.15 0.09
Operating Margin 2668.48 0.07 < 0.005
ROA 1288.25 0.02 < 0.005
ROE 1323.98 0.03 < 0.005
ROIC 1126.82 0.02 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002441.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002441.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002441.SZ is permitted for members.